中基健康(000972) - 2025 Q1 - 季度财报

Financial Performance - The company's revenue for Q1 2025 was ¥78,693,422.51, a decrease of 34.01% compared to ¥119,254,852.12 in the same period last year[4] - The net profit attributable to shareholders was -¥7,255,722.34, compared to a profit of ¥5,982,705.03 in the previous year, indicating a significant decline[4] - Total operating revenue decreased to ¥78,693,422.51 from ¥119,254,852.12, representing a decline of approximately 34.0% year-over-year[15] - Net profit for the period was a loss of ¥7,793,083.95 compared to a profit of ¥6,179,766.79 in the previous period, indicating a significant downturn[16] Cash Flow - The net cash flow from operating activities was -¥164,352,642.87, a stark contrast to ¥15,146,638.30 in the same period last year[4] - Operating cash flow net amount was negative at ¥-164,352,642.87, contrasting with a positive cash flow of ¥15,146,638.30 in the prior period[17] - Cash received from operating activities totaled ¥105,238,408.49, down from ¥122,031,810.98, a decline of about 13.7%[17] - Cash outflow from operating activities was ¥269,591,051.36, significantly higher than ¥106,885,172.68 in the previous period, indicating increased cash usage[17] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,618,568,753.64, down 6.96% from ¥1,739,625,960.93 at the end of the previous year[4] - The total current assets decreased from 1,256,179,871.30 yuan to 1,145,269,754.82 yuan, a reduction of approximately 8.83%[12] - The total liabilities decreased from 1,559,200,657.09 yuan to 1,450,499,701.23 yuan, a reduction of approximately 6.97%[12] - Total liabilities amounted to ¥1,643,424,012.13, down from ¥1,756,688,135.47, reflecting a decrease of approximately 6.4%[13] Shareholder Information - The total number of common shareholders at the end of the reporting period is 32,976[9] - The largest shareholder, Xinjiang Production and Construction Corps Sixth Division State-owned Assets Management Co., holds 16.18% of shares, totaling 124,769,223 shares, with 59,621,900 shares pledged[9] - The company has no preferred shareholders as of the reporting period[10] - The company has no significant changes in the participation of major shareholders in margin trading and securities lending[10] Costs and Expenses - Total operating costs decreased to ¥85,805,792.64 from ¥113,703,122.68, a reduction of about 24.6% year-over-year[15] - The company incurred financial expenses of ¥11,324,232.39, an increase of 110.12% due to higher interest expenses from increased bank loans[7] - The company incurred financial expenses of ¥11,324,232.39, which increased from ¥5,389,520.34, marking an increase of approximately 109.4%[16] Inventory and Receivables - Inventory decreased from 983,492,604.16 yuan to 930,779,051.08 yuan, a decline of approximately 5.36%[12] - Accounts receivable decreased slightly from 52,847,606.90 yuan to 51,935,154.94 yuan, a decrease of about 1.73%[11] Product Pricing - The average selling price of the main product, large barrel sauce, decreased by approximately 60% compared to the same period last year, contributing to the revenue decline[7] Tax and Refunds - The company received tax refunds of ¥137,815.82, a significant increase of 7843.60% compared to ¥1,734.93 in the previous year[8] Acquisition Plans - The company is planning to acquire 100% equity of Xinjiang New Energy Chemical Co., Ltd. through a share issuance, which may lead to a change in actual control[10] Cash and Equivalents - Cash and cash equivalents decreased by 38.40% to ¥98,541,926.86, primarily due to payments for raw material purchases[7] - Cash and cash equivalents decreased from 159,980,401.08 yuan to 98,541,926.86 yuan, a decline of approximately 38.38%[11] - The ending balance of cash and cash equivalents was $83,141,926.86, down from $149,680,401.08 at the beginning of the period[18] - The company reported a negative impact of -$1.71 from foreign exchange fluctuations on cash and cash equivalents[18] Financing Activities - Net cash flow from financing activities was $100,949,382.06, a significant improvement compared to a net outflow of $73,913,282.71 in the previous period[18] - Total cash inflow from financing activities amounted to $179,080,000.00, while cash outflow totaled $78,130,617.94[18] - Cash dividends and interest payments totaled $9,296,105.23, showing stability in shareholder returns[18]